Release of our first CSR Report!
We’re excited to announce the publication of our first CSR Report!
HTL Biotechnology CEO François Fournier spoke to leading Korean media DongA Ilbo, reaffirming Korea’s strategic importance and the strong, long-standing ties with Korean customers.
We are excited to share that HTL Biotechnology is present at the AMWC 2025 in Monaco.
On March 10 to 12, 2025, HTL Biotechnology was proud to be present at CIBE (China International Beauty Expo) in Guangzhou, reaffirming our commitment to the dermatology and beauty industries.
Earlier this year, during the IMCAS World Congress, we interviewed three experts in the field of aesthetic medicine and are thrilled to share these interviews !
Feel the difference with HTL inside
Feel the difference with HTL inside
A global company with a heart in Brittany
HTL Biotechnology is the pioneer in the development and sustainable production of pharmaceutical grade biopolymers, used to develop life-changing treatments for millions of patients worldwide.
Backed by 30 years of expertise, we now work with more than 100 clients in 30 countries. In total, over 400 million syringes of hyaluronic acid have been safely used since 2006.
As the market leader in pharmaceutical grade biopolymers for medical use, we work every day to :